Disturbance of the Intestinal Ecosystem by Antimicrobial Agents

  • P. C. Braga
Conference paper


Antibiotics are the most widely used class of drugs and differ from other pharmacological agents commonly used for therapy in that their action is addressed to cells not belonging to human body, for example, bacteria, while other drugs acts on cells of the human body. This means that among the huge number of substances with antimicrobial activity, only those that have specific affinity for micro-organisms and not for human cells are chosen for therapy.


Antimicrobial Agent Clostridium Difficile Intestinal Microflora Pseudomembranous Colitis Fecal Flora 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Allo, M, Salva, J Jr, Fekety, R et al. (1979) Prevention of clindamycm-induced colitis in hamsters by Clostridia sordelli antitoxin. Gastroenterology 76: 351–355PubMedGoogle Scholar
  2. 2.
    Alvisi, V, D’Ambrosi, A, Loponte, A, Pazzi, P, Greco, A, Zangirolami, A, Palazzini, E (1987) Rifaximin, a rifamycin derivative for the use in the treatment of intestinal bacterial infections in seriously disabled patients. J Int Med Res 15: 59–56Google Scholar
  3. 3.
    Arabi, T, Dimock, F, Burdon, DW et al. (1979) Influence of neomycin and metronidazole on colonic microflora of volunteers. J Antimicrob Chemother 5: 531–537PubMedCrossRefGoogle Scholar
  4. 4.
    Aronsson, B, Möllby, R, Nord, CE (1985) Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden 1980/82. J Infect Dis 151: 476–481PubMedCrossRefGoogle Scholar
  5. 5.
    Arvidsson, A, Alvan, G, Angelin, B, Borga, O, Nord, CE (1982) Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicr Chemother 10: 207–215CrossRefGoogle Scholar
  6. 6.
    Ashkenazi, S, Cleary, TG, Pickering, LK (1989) Bacterial toxins associated with diarrheal disease. In: Lebenthal, E, Duffey, M (eds) Textbook of secretory diarrhea. Raven, New YorkGoogle Scholar
  7. 7.
    Bartlett, JG, Gorbach, SL (1977) Pseudomembranous enterocolitis (antibiotic-related colitis). Ad Intern Med 22: 455–460Google Scholar
  8. 8.
    Bartlett, JG, Tedesco, FJ, Shull, S, Lowe, B (1979) Symptomatic relaps after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology 78: 431–434Google Scholar
  9. 8a.
    Bergan, T (1986) Pharmacokinetic differentiation and consequences for normal microflora. Scand J Infect Dis 49 (Suppl): 91–99Google Scholar
  10. 9.
    Bint, AJ, Burtt, I (1980) Adverse antibiotic drug interaction. Drugs 20: 57–69PubMedCrossRefGoogle Scholar
  11. 10.
    Bodey, GP, Fainstein, V, Garcia, I, Rosenbaum, B, Wong, Y (1983) Effect of broad-spectrum cephalosporins on the microbial flora of recipients. J Infect Dis 148: 892–897PubMedCrossRefGoogle Scholar
  12. 11.
    Boero, M, Berti, E, Morgando, A, Verme, G (1990) Terapia della colite da Clostridium difficile: risultati di uno studio randomizzato aperto rifaximina vs. vancomicina. Microbiol Medica 5: 74–77Google Scholar
  13. 12.
    Bowden, TA, Jr, Mausberger, AR, Jr, Lykins, LE (1981) Pseumomembranous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 47: 178–184PubMedGoogle Scholar
  14. 13.
    Braga, PC (1991) Interaction of antibiotics on enteric microflora. In Braga, PC, Guslandi, M, Tittobello, A (eds) Drugs in gastroenterology. Raven, New York, pp 509–517Google Scholar
  15. 14.
    Braga, PC (1991) Enteric microflora and its regulation. In: Braga PC, Guslandi M, Tittobello A (eds) Drugs in gastroenterology. Raven, New York, pp 501–507Google Scholar
  16. 15.
    Braga, PC (1991) Microorganisms regulating enteric microflora. In: Braga, PC, Guslandi, M, Tittobello, A (eds) Drugs in gastroenterology. Raven, New York, pp 518–523Google Scholar
  17. 16.
    Braga, PC, Del Mastro, S, Fraschini, F (1979) Attuali orientamenti della chemioterapia nelle infezioni da batteri anaerobi. Biol Med 1: 73–88Google Scholar
  18. 17.
    Braga, PC, Del Mastro, S, Fraschini, F (1980) Il metronidazolo nella terapia delle infezioni da batteri anaerobi. Biol Med 2: 207–243Google Scholar
  19. 18.
    Burbige, EJ and Milligan, FD (1975) Pseumembranous colitis. Association with antibiotics and therapy with cholestyramine. J Am Med Assoc 231: 1157–1158CrossRefGoogle Scholar
  20. 19.
    Cameron, A, Thomas, M (1977) Pseudomembranous colitis and co-trimoxazole. Br Med J 1: 1321–1323PubMedCrossRefGoogle Scholar
  21. 20.
    Chang, TW, Onderdonk, AB, Bartlett, JG (1978) Anion exchange resins in antibiotic-associated colitis. Lancet 2: 258–259PubMedCrossRefGoogle Scholar
  22. 21.
    Chang, TW, Garbadi, SL, Bartlett, JG, Saginur, R (1990) Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin. Gastroenterology 78: 1584–1586Google Scholar
  23. 22.
    Cohen, MH (1976) Effect of oral prophylactic broad spectrum nonadsorbable antibiotics on the gastrointestinal absorption of nutrients and methotrexate in small cell bronchogenic carcinoma patients. Cancer 38: 1556–1601PubMedCrossRefGoogle Scholar
  24. 23.
    Cudmore, M, Silva, J, Fekety, R (1980) Clostridial enterocolitis produced by antineoplastic agents in hamsters and humans. Curr Chemother Infect Dis 2: 1460–1463Google Scholar
  25. 24.
    Drasar, BS, Barrow, PA (1985) Intestinal microbiology. American Society for Microbiology, WashingtonGoogle Scholar
  26. 25.
    Dukes, MMG (ed) (1988) Meyler’s side effects of drugs. Elsevier, AmsterdamGoogle Scholar
  27. 26.
    Edlund, C, Nord, CE (1986) Comparative in vitro activities of ciprofloxacin enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile. Scand J Infect Dis 18: 149–151PubMedCrossRefGoogle Scholar
  28. 27.
    Fee, HJ, Ament, ME, Holmes, EC (1977) Pseudomembranous colitis associated with cephazolin therapy. Am J Surg 133: 247–251PubMedCrossRefGoogle Scholar
  29. 28.
    Fekety, R, O’Connor, R, Silva, J (1983) Rifampin and pseudomembranous colitis. Rev Infect Dis 5 (Suppl 3) 524CrossRefGoogle Scholar
  30. 29.
    Finegold, SM (1970) Interaction of antimicrobial therapy and intestinal flora. Am J Clin Nutr 23: 1466–1471PubMedGoogle Scholar
  31. 30.
    Finegold, SM, Posnick, DJ, Miller, KLG, Hewitt, WL (1965) The effects of various antibacterial compounds on the normal human fecal flora. Ernährungsforschung 10: 316–341Google Scholar
  32. 31.
    Finegold, SM, Davis, A, Miller, LG (1967) Comparative effect of broad-spectrum antibiotics on nonspore-forming anaerobes and normal bowel flora. Ann New York Acad Sci 145: 268–281CrossRefGoogle Scholar
  33. 32.
    Friedman, GD, Gerard, MJ, Ury, HK (1976) Clindamycin and diarrhoea. J Am Med Assoc 236: 2498–2501CrossRefGoogle Scholar
  34. 33.
    George, WL, Rolfe, RD, Harding, GKM et al. (1982) Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 143: 40–48Google Scholar
  35. 34.
    Grünenberg, RN, Ridgway, GL, Cremer, AWF, Felmingham, D (1983) The sensitivity of gram-positive pathogens to teichomycin and vancomycin. Drug Exp Clin Res 9: 139–141Google Scholar
  36. 35.
    Heimdahl, A, Nord, CE (1983) Influence of doxycycline on the normal human flora and colonization of the oral cavity and colon. Scand J Infect Dis 15: 293–302PubMedGoogle Scholar
  37. 36.
    Heimdahl, A, Nord, CE (1979) Effect of Phenoxymethylpenicillin and clindamycin on the oral, throat an fecal microflora of man. Scand J Infect Dis 11: 233–242PubMedGoogle Scholar
  38. 37.
    Heimdahl, A, Nord, CE (1982) Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonisation of the intestinal tract. Eur J Clin Micr 1:38–48CrossRefGoogle Scholar
  39. 38.
    Kager, L, Ljungdahl, I, Malmborg, AS, Nord, CE (1981) Effect of imidazole prophylaxis on the normal macroflora in patients undergoing colorectal surgery. Scand J of Infect Dis 26: 84–91Google Scholar
  40. 39.
    Kager, L, Malmborg, AS, Sjostedt, S, Nord, CE (1983) Concentrations of ampi-cillin plus sulbactam in serum and intestinal mucosa and on the colonic microflora in patients undergoing colorectal surgery. Eur J Clin Micr 2: 559–563CrossRefGoogle Scholar
  41. 40.
    Kager, L, Malmborg, AS, Nord, CE (1983) Impact of short-term as compared with long-term prophylaxis with cefoxitin on the colonic microflora in patients undergoing colorectal surgery. Drugs Exptl Clin Res 9: 387–392Google Scholar
  42. 41.
    Kager, L, Malmborg, AS, Nord, CE, Sjostedt, S (1983) The effect of piperacillin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Infection 11: 251–254PubMedCrossRefGoogle Scholar
  43. 42.
    Kager, L, Brismar, B, Malmborg, AS, Nord, CE (1985) Effect of aztreonam on the colon microflora in patients undergoing colorectal surgery. Infection 13: 111–114PubMedCrossRefGoogle Scholar
  44. 43.
    Keighley, MRB, Burdon, DW, Arabi, Y et al. (1978) Randomised trial of vancomycin for pseudomembranous colitis and post-operative diarrhea. Brit Med J 2: 1667–1669PubMedCrossRefGoogle Scholar
  45. 44.
    Keighley, MRB, Burdon, DW, Alexander-Williams, J et al. (1978) Diarrhoea and pseudomembranous colitis after gastrointestinal operations. Lancet 2, 1165PubMedCrossRefGoogle Scholar
  46. 45.
    Knothe, H (1963) Darmflora und Antibiotika unter besonderer Berücksichtigung der Tetracycline. Deutscher Medizinische Wochenschrift 88: 1469–1477CrossRefGoogle Scholar
  47. 46.
    Knothe, H, Wiedermann, B (1965) Die Wirkung von Ampicillin auf die Darmflora des gesunden Menschen. Zentralblatt Bakteriologie 1 Abt Orig 197: 234–243Google Scholar
  48. 47.
    Kuceys, A, Bennet, N, MCK (1989) The use of antibiotics. Heineman Medical Books, Oxford, pp 1064–1072Google Scholar
  49. 48.
    Leigh, DA, Simmons, K (1978) Effect of clindamycin and lincomycin therapy of faecal flora. J Clin Pathol 31: 439–443PubMedCrossRefGoogle Scholar
  50. 49.
    Lindenbaum, J, Rund, DG, Butler, VP, Jr et al. (1981) Inactivation of digoxin by the gut flora, reversal by antibiotic therapy. N Engl J Med 305: 789–794PubMedCrossRefGoogle Scholar
  51. 50.
    Lombardi, P, Goldin, B, Bontin, E, Gorbach, SL (1978) Metabolism of androgens and estrogens by human fecal microorganisms. J Steroid Biochem 9: 795–801PubMedCrossRefGoogle Scholar
  52. 51.
    Matuchousky, C, Aries, J, Maire, P (1978) Metromidazole for antibiotic associated pseudomembranous colitis. Lancet 2: 580–581CrossRefGoogle Scholar
  53. 52.
    Mogg, GM, Keighley, M, Burdon, D, et al. (1979) Antibiotic-associated colitis, a review of 66 cases. Br J Surg 66: 738–742PubMedCrossRefGoogle Scholar
  54. 53.
    Newsom, SWB, Matthews, J, Rampling, AM (1985) Susceptibility of Clostridium difficile strains to new antibiotics: quinolones, efrotomycin, teicoplanin and imipenem. J Antimicr Chemother 15: 648–649CrossRefGoogle Scholar
  55. 54.
    Noble, JT, Barza, M (1985) Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection? Drugs 30: 175–181PubMedCrossRefGoogle Scholar
  56. 55.
    Nord, CE, Heimdahl, A, Kager, I, Malmborg, AS (1984) The impact of different antimicrobial agents on the normal gastrointestinal flora. Rev Infec Dis 6 (Suppl 1): S270–S275CrossRefGoogle Scholar
  57. 56.
    Nord, CE, Kager, L, Philipsson, A, Stiernstedt, G (1984) Impact of imipenem/ cilastatin therapy on faecal flora. Eur J Clin Microbiol 3: 475–477PubMedCrossRefGoogle Scholar
  58. 57.
    Nord, CE, Bergan, T, Aase, S (1986) Impact of azlocillin on the colon microflora. Scand J Infect Dis 18: 163–166PubMedCrossRefGoogle Scholar
  59. 58.
    Nord, CE, Heimdahl, A, Kager, L (1986) Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Scand J Infect Dis 49 (Suppl): 64–72Google Scholar
  60. 59.
    Oldenbuirger, TR, Miller, MS (1980) Treatment of pseudomembranous colitis with oral metroidazole after relapse following vancomycin. Am J Gastroenterol 74: 359–360Google Scholar
  61. 60.
    Pantosti, A, Luzzi, I, Cardines, R, Gianfrilli, P (1985) Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine. Antimicr Angets Chemother 28: 847–848Google Scholar
  62. 61.
    Pashby, NL, Bolton, RP, Sherriff, RJ (1979) Oral metronidazole in Clostridium difficile colitis. Br Med J 1: 1605–1606PubMedCrossRefGoogle Scholar
  63. 62.
    Read, L, Cave-Smith, JR (1977) Pseudomembranous enterocolitis complicating ampicillin therapy. Postgrad Med J 53: 324–327PubMedCrossRefGoogle Scholar
  64. 63.
    Reeves, DS (1986) The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials. J Antimicr Chemoth 18 (Suppl D): 89–102Google Scholar
  65. 64.
    Reimers, D, Nopcke-Fink, L, Brever, H (1974) Rifampin and “pill” do not go well together. J Am Med Ass 227: 608Google Scholar
  66. 65.
    Ripa, S, Mignini, F, Prenna, M, Falcioni, E (1987) In vitro antibacterial activity of rifaximin against Clostridium difficile, Compylobacter jejunii and Yersinia spp. Drugs Exp Clin Res 13: 483–488PubMedGoogle Scholar
  67. 66.
    Robertson, MB, Breen, KJ, Desmond, PV et al. (1977) Incidence of antibiotic-related diarrhoea and pseudomembranous colitis. Med J Anst 1: 243–247Google Scholar
  68. 67.
    Sagimur, R, Hawley, CR, Bartlett, JG (1980) Colitis associated with metronidazole therapy. J Infect Dis 141: 772–775CrossRefGoogle Scholar
  69. 68.
    Sanders, Jr, WE, Sanders, CC (1984) Modification of normal flora by antibiotics: effects on individuals and the environment. In: Root, RK, Saude, MA (eds) New dimensions in antimicrobial therapy. Churchill Livingstone, New York, pp 217–241Google Scholar
  70. 69.
    Sakata, H, Fujita, K, Yoshioka, H (1986) The effect of antimicrobial agents on fecal flora of children. Antimicr Ag Chemother 29: 225–229Google Scholar
  71. 70.
    Savage, DC (1977) Microbial ecology of the gastro-intestinal tract. Ann Rev Microbiol 31: 107–118CrossRefGoogle Scholar
  72. 71.
    Savage, DC (1983) Microbial ecology of the gastrointestinal tract. In: Hallgren B (ed) Nutrition and the intestinal flora. Almqvist and Wiksell, Uppsala, pp 17–23Google Scholar
  73. 72.
    Similä, S, Kouvalainen, K, Mäkelä, P (1976) Pseudomembranous colitis after amoxycillin. Lancet 2: 317PubMedCrossRefGoogle Scholar
  74. 73.
    Sjövall, J, Huitfeldt, B, Magni, L, Nord, CE (1986) Effect of beta-lactam prodrugs on human intestinal microflora. Scand J Infect Dis 49 (Suppl) : 73–83Google Scholar
  75. 74.
    Stanley, RJ, Nelson, GL, Tedesco, FJ (1974) The spectrum of radiographic findings in antibiotic-related pseudo-membranous colitis. Radiology 111 : 519–524PubMedGoogle Scholar
  76. 75.
    Stephen, J, Osborne, MP (1988) Pathophysiological mechanisms in diarrhocal disease. In: W Donadie, E Griffiths, J Stephen (eds) Bacteria infections of respiratory and gastrointestinal mucosae. IRL Press for Society for General Microbiology, pp 149–170Google Scholar
  77. 76.
    Tedesco, FJ (1977) Clindamycin and colitis: a review. J Infect Dis 135 (suppl): 95–102CrossRefGoogle Scholar
  78. 77.
    Tedesco, FJ (1980) Antibiotic associated PMC. Gastroenterology 78: 192Google Scholar
  79. 78.
    Tedesco, FJ, Stanley, RJ, Alfers, DH (1974) Diagnostic features of clindamycin-associated pseudomembranous colitis. N Engl J Med 290: 841–846PubMedCrossRefGoogle Scholar
  80. 79.
    Tedesco, FJ, Barton, RW, Alphers, HD (1974) Clyndamycin-associated colitis. Ann Intern Med 81: 429–433PubMedGoogle Scholar
  81. 80.
    Tedesco, FJ, Markham, R, Gurwith, M et al. (1978) Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 2: 226PubMedCrossRefGoogle Scholar
  82. 81.
    Thomson, G, Clark, AH, Hare, K, Spilg WGS (1981) Pseumembranous colitis after treatment with metronidazole. Br Med J 282: 864–865CrossRefGoogle Scholar
  83. 82.
    Tures, JF, Townsend, WF, Rose, HD (1976) Cephalosporin-associated pseudomembranous colitis. J Am Med Assoc 236: 948–953CrossRefGoogle Scholar
  84. 83.
    Van Saene, JJM, Van Saene, HKF, Geitz, JN, Tarko-Smit, NJP, Lerk, CF (1986) Quinolones and colonisation resistance in human volunteers. Pharmaceutish Weekblad Scientific Edition 8: 67–71CrossRefGoogle Scholar
  85. 84.
    Wade, JC, de Jough, CA, Newman, KA, Crowley, J, Wiernik, PH, Schimpff, SC (1983) Selective antimicrobial modulation as prophylaxis against infection during granulocytopaenia: trimethoprim-sulfamethoxazole vs nalidixic acid. J Infect Dis 147: 624–634PubMedCrossRefGoogle Scholar
  86. 85.
    Weinstein, AJ, Alanis, A (1985) Antibiotic side effects. In: Ristuccia AM, Cunha BA (eds) Antimicrobial therapy. Raven, New YorkGoogle Scholar
  87. 86.
    Wu, H (1982) Spontaneous persistent pseudomembranous colitis related to Clostridium difficile in ischaemic bowel disease. Br Med J 284: 1606–1610CrossRefGoogle Scholar
  88. 87.
    Zintel, HA (1947) Streptomycin in peritonitis. Am J Med 5: 443–448CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • P. C. Braga
    • 1
  1. 1.Department of Pharmacology, School of MedicineUniversity of MilanItaly

Personalised recommendations